Neutralization Determinants on Poxviruses
Open Access
Abstract
Smallpox was a highly contagious disease caused by the variola virus. The disease affected millions of people over thousands of years and variola virus ranked as one of the deadliest viruses in human history. The complete eradication of smallpox in 1980, a major triumph in medicine, was achieved through a global vaccination campaign using a less virulent poxvirus, vaccinia virus. Despite this success, the herd immunity established by this campaign has significantly waned, and concerns are rising about the potential reintroduction of variola virus as a biological weapon or the emergence of zoonotic poxviruses. These fears were further fueled in 2022 by a global outbreak of monkeypox virus (mpox), which spread to over 100 countries, thereby boosting interest in developing new vaccines using molecular approaches. However, poxviruses are complex and creating modern vaccines against them is challenging. This review focuses on the structural biology of the six major neutralization determinants on poxviruses (D8, H3, A27, L1, B5, and A33), the localization of epitopes targeted by neutralizing antibodies, and their application in the development of subunit vaccines.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-22-CE11-0003-01)
This publication has 109 references indexed in Scilit:
- Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune responseVirology Journal, 2013
- The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 proteinVirology, 2010
- A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challengeVaccine, 2010
- There is an A33-dependent mechanism for the incorporation of B5-GFP into vaccinia virus extracellular enveloped virionsVirology, 2010
- Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primatesVaccine, 2009
- The immunology of smallpox vaccinesCurrent Opinion in Immunology, 2009
- Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycansVirology, 2009
- Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 proteinVirology, 2007
- Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challengesVaccine, 2007
- A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boostVaccine, 2007